Benzinga · Feb 26, 2026
IN
NASDAQ · INSP
Inspire Medical Systems, Inc.
Healthcare · Medical - Devices
$58.28
Down-$0.43 (-0.73%)
Updated Aug 13, 2026, 6:33 PM
SID Score
4.1/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 4.05B
- P/E ratio
- 76.09
- Dividend yield
- 0.00%
- 52-week range
- $38.91 – $147.03
- Volume
- 571.49K
- Avg. volume
- 1.3M
Price performance
INSP price history
1M range · 21 trading sessions · Daily adjusted prices
INSP closed at $58.28 after 21 trading sessions, up 15.41% for the selected period.
- Last close
- $58.28
- Period change
- +15.41%
- Period low
- $49.19
- Period high
- $64.14
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 12, 2026 | $58.03 | $59.12 | $57.20 | $58.28 | 571.49K |
| Aug 11, 2026 | $59.20 | $60.75 | $59.07 | $59.13 | 385.37K |
| Aug 10, 2026 | $59.53 | $61.3123 | $59.35 | $59.72 | 585.41K |
| Aug 7, 2026 | $58.65 | $60.505 | $58.285 | $60.16 | 538.9K |
| Aug 6, 2026 | $59.60 | $60.44 | $58.68 | $58.89 | 681.94K |
| Aug 5, 2026 | $63.32 | $63.342 | $59.76 | $60.09 | 1.45M |
| Aug 4, 2026 | $64.16 | $66.205 | $59.50 | $64.14 | 2.33M |
| Aug 3, 2026 | $51.21 | $52.80 | $51.21 | $52.22 | 992.13K |
| Jul 31, 2026 | $49.92 | $50.39 | $49.02 | $50.21 | 672.28K |
| Jul 30, 2026 | $50.27 | $50.66 | $48.75 | $50.02 | 676.37K |
| Jul 29, 2026 | $51.62 | $52.49 | $50.56 | $51.07 | 1.05M |
| Jul 28, 2026 | $48.21 | $52.47 | $48.21 | $51.97 | 935.06K |
| Jul 27, 2026 | $50.17 | $51.27 | $49.7177 | $50.93 | 944.84K |
| Jul 24, 2026 | $51.57 | $52.06 | $49.19 | $49.19 | 658.38K |
| Jul 23, 2026 | $50.30 | $50.87 | $48.80 | $50.81 | 709.82K |
| Jul 22, 2026 | $52.01 | $52.52 | $50.115 | $50.40 | 755.92K |
| Jul 21, 2026 | $52.29 | $53.50 | $51.84 | $52.49 | 638.94K |
| Jul 20, 2026 | $50.53 | $53.40 | $50.53 | $53.27 | 784.13K |
| Jul 17, 2026 | $51.04 | $51.46 | $49.68 | $50.60 | 664.6K |
| Jul 16, 2026 | $51.58 | $53.01 | $51.02 | $51.54 | 882.24K |
| Jul 15, 2026 | $49.21 | $51.43 | $48.765 | $50.50 | 679.54K |
Latest INSP news
The latest Smart Investors Daily articles mentioning INSP.
Stock researchCompany · Overview
INSP research
Overview
Company profile and research snapshot.
Company profile
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $139.92
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 4, 2026 | Evercore ISI Group | In-Line | — |
| Aug 4, 2026 | Piper Sandler | Neutral | — |
| Aug 4, 2026 | Baird | Neutral | — |
| Aug 4, 2026 | Oppenheimer | Outperform | — |
| Aug 4, 2026 | Truist Securities | Hold | — |
News briefing
No generated briefing is available yet.
Benzinga · Feb 26, 2026
Inspire Medical Systems shares are trading higher after a KeyBanc note indicated that CMS appears ready to add INSP V Specific C-Codes in April 2026 IOCE update
Benzinga · Feb 26, 2026
Inspire Medical Systems Trading Halted
Fintel · Feb 25, 2026
Inspire Medical Systems (INSP) Price Target Decreased by 27.11% to 95.55
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
